| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* University Children’s Hospital and
Institute of Pathology, University of Ulm, Ulm, Germany
Elimination of T cells during an immune response is mediated by activation-induced cell death (AICD) and CD95-mediated apoptosis. Chronic graft-vs-host disease and T cell-mediated autoimmune diseases are caused by the persistence of activated T cells that escaped tolerance induction by deletion or silencing. To mimic the in vivo situation of long-term activated T cells, we generated an in vitro system using HLA-A1-specific T cells, weekly restimulated by Ag. While short-term activated T cells (two to five rounds of stimulation) were CD95 sensitive and susceptible to AICD, T cells stimulated more than eight times acquired constitutive CD95 resistance and exhibited reduced AICD. Phenotypically, these long-term activated T cells could be identified as effector/memory T cells. The expression of the proforms of the CD95 receptor initiator caspases, caspase-8 and -10, and the effector caspase-3 was strongly decreased in these cells, and only active caspase fragments were detected. In contrast to short-term activated T cells, constitutive CD95 receptor clustering was observed on the cell surface, and caspase-8 was bound to the CD95 receptor in the absence of receptor triggering. After further cross-linking of CD95, additional formation of the death-inducing signaling complex (DISC) was strongly impaired. Reduced DISC formation in long-term activated T cells was associated with the loss of PTEN expression and the increased phosphorylation of protein kinase B. Inhibitors of phosphoinositol 3-kinase restored CD95 sensitivity and DISC formation in long-term activated T cells. These data suggest that defective CD95 signaling in effector/memory T cells may contribute to the apoptosis resistance toward physiological stimuli in T cells mediating tissue destruction in vivo.
This article has been cited by other articles:
|
|
 |
|
  J. W. Peacock, J. Palmer, D. Fink, S. Ip, E. M. Pietras, A. L.-F. Mui, S. W. Chung, M. E. Gleave, M. E. Cox, R. Parsons, et al. PTEN Loss Promotes Mitochondrially Dependent Type II Fas-Induced Apoptosis via PEA-15 Mol. Cell. Biol., March 1, 2009; 29(5): 1222 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hebert, S. Potin, M. Sebbagh, J. Bertoglio, J. Breard, and J. Hamelin Rho-ROCK-Dependent Ezrin-Radixin-Moesin Phosphorylation Regulates Fas-Mediated Apoptosis in Jurkat Cells J. Immunol., November 1, 2008; 181(9): 5963 - 5973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Singh, M. Nagarkatti, and P. Nagarkatti Primary Peripheral T Cells Become Susceptible to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin-Mediated Apoptosis in Vitro upon Activation and in the Presence of Dendritic Cells Mol. Pharmacol., June 1, 2008; 73(6): 1722 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, P. K. Epling-Burnette, J. S. Painter, J. Zou, F. Bai, S. Wei, and T. P. Loughran Jr Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia Blood, February 1, 2008; 111(3): 1610 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fischer-Posovszky, H. Hebestreit, A. K. Hofmann, G. Strauss, P. Moller, K.-M. Debatin, and M. Wabitsch Role of CD95-Mediated Adipocyte Loss in Autoimmune Lipodystrophy J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1129 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maksimow, T. S. Soderstrom, S. Jalkanen, J. E. Eriksson, and A. Hanninen Fas costimulation of naive CD4 T cells is controlled by NF-{kappa}B signaling and caspase activity J. Leukoc. Biol., February 1, 2006; 79(2): 369 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Soderstrom, S. D. Nyberg, and J. E. Eriksson CD95 capping is ROCK-dependent and dispensable for apoptosis J. Cell Sci., May 15, 2005; 118(10): 2211 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bosque, J. Pardo, M{a} J. Martinez-Lorenzo, M. Iturralde, I. Marzo, A. Pineiro, M{a} A. Alava, J. Naval, and A. Anel Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression J. Leukoc. Biol., April 1, 2005; 77(4): 568 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. K. Chou, D. M. Edwards, A. D. Weinberg, A. A. Vandenbark, B. L. Kotzin, A. P. Fontenot, and G. G. Burrows Activation Pathways Implicate Anti-HLA-DP and Anti-LFA-1 Antibodies as Lead Candidates for Intervention in Chronic Berylliosis J. Immunol., April 1, 2005; 174(7): 4316 - 4324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Lawson, R. Baccala, J. Song, M. Croft, D. H. Kono, and A. N. Theofilopoulos Deficiency of the Cyclin Kinase Inhibitor p21(WAF-1/CIP-1) Promotes Apoptosis of Activated/Memory T Cells and Inhibits Spontaneous Systemic Autoimmunity J. Exp. Med., February 17, 2004; 199(4): 547 - 557. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
